Transforming drug discovery: Novo Nordisk uses the power of AI and Azure with Microsoft Research
Developing high-quality medicine is a resource-intense endeavor that requires collaboration across Novo Nordisk. Novo Nordisk aimed to scale a pipeline of drug discovery, development, and data science capabilities with AI and machine learning. In partnership with Microsoft Research, the teams built a Novo Nordisk AI platform on Azure AI and data stacks. Novo Nordisk amplified its culture of innovation by leveraging Microsoft Azure platform's AI capabilities across many use cases. The teams recently published initial results with predictive AI models for advanced risk detection in cardiovascular diseases, including an algorithm that can predict patients' cardiovascular risk better than the best clinical standards. Read this case study for lessons learned.
How is Novo Nordisk using AI in drug discovery?
Novo Nordisk is leveraging AI and machine learning to enhance its drug discovery and development processes. By building a dedicated AI platform on Microsoft Azure, the company is able to scale its capabilities and improve collaboration among life scientists, computational biologists, and data scientists. This approach has led to the development of predictive AI models that can detect cardiovascular disease risks more effectively than traditional clinical standards.
What are the benefits of the partnership with Microsoft Research?
The partnership with Microsoft Research allows Novo Nordisk to combine its extensive domain expertise in life sciences with Microsoft's advanced AI capabilities. This collaboration has resulted in the creation of a comprehensive AI platform that supports various use cases, including regulatory affairs and trial design, enabling more efficient and innovative approaches to drug discovery.
What impact does AI have on patient care?
AI is reshaping patient care at Novo Nordisk by enabling the definition of patients' risks for developing diseases, which is essential for precision medicine. With over 100 years of data on insulin research, the integration of AI allows Novo Nordisk to provide better treatment options for conditions related to diabetes, such as obesity and cardiovascular diseases, ultimately improving patient outcomes.
Transforming drug discovery: Novo Nordisk uses the power of AI and Azure with Microsoft Research
published by Guden Limited
Gudens helps global companies modernize IT, optimize data architectures, and ensure security and scalability across public, private, and hybrid clouds, so they can run their mission-critical systems and operations with confidence.
Why Gudens?
We are experts in cloud computing, with a deep understanding of the latest technologies and trends.
We offer tailored support for businesses of all sizes, from startups to Fortune 500 companies.
We are committed to helping our customers achieve their business goals through cloud computing.
Our services:
Cloud readiness assessment
Cloud strategy
Cloud migration
Cloud service ROI
Whether you are just starting out with cloud computing or looking to optimize your existing cloud environment, Gudens can help you every step of the way.
Contact us today to learn more about how we can help you achieve your cloud computing and digital transformation goals.
Sign in with LinkedIn